Evidence map›Paper›PMID 36196997›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2022

Gene dosage changes in KCTD13 result in penile and testicular anomalies via diminished androgen receptor function.

Abhishek Seth, Armando Rivera, Ahmed Chahdi, In-Seon Choi, Olga Medina-Martinez, Shaye Lewis, Marisol O'Neill, Alex Ridgeway, Joshua Moore, Carolina Jorgez and 1 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Androgen receptor ubiquitination links KCTD13 to genitourinary tract defects.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  5. The pleiotropic spectrum of proximal 16p11.2 CNVs.American journal of human genetics · 2024
    Review
  6. Article
  7. Novel evidence of CNV deletion inFrontiers in pediatrics · 2024
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Abhishek SethScott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-4071-3588
Armando RiveraScott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-7076-8566
Ahmed ChahdiDepartment of Surgery, Nemours Children's Hospital, Orlando, Florida, USA.ORCID https://orcid.org/0000-0001-9048-4931
In-Seon ChoiScott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-5237-0255
Olga Medina-MartinezScott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0003-3515-9786
Shaye LewisScott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-8937-0857
Marisol O'NeillCenter for Reproductive Medicine, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-3154-1112
Alex RidgewayCenter for Reproductive Medicine, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-6055-6375
Joshua MooreCenter for Reproductive Medicine, Baylor College of Medicine, Houston, Texas, USA.
Carolina JorgezScott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-9203-6331
Dolores J LambScott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-4389-5065
Baylor College of Medicine · USNemours Children's Clinic · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
Multidisciplinary K12 Urologic Research (KURe) Career Development ProgramK12DK083014 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI LAMB, DOLORES JEAN · 2008 to 2017
$6.0M
Improving the Diagnosis of Congenital Genitourinary Defects.R01DK078121 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI LAMB, DOLORES JEAN · 2007 to 2021
$4.8M
The Role of E3-Ubiquitin Ligase Complex in Genitourinary Tract Development and Function.R01HD100985 · NICHD · NEMOURS CHILDREN'S HOSPITAL, ORLANDO · PI SETH, ABHISHEK · 2020 to 2024
$1.6M
UROLOGIC RESEARCH CAREER DEVELOPMENT PROGRAM (T32)T32DK007763 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI LAMB, DOLORES JEAN · 1999 to 2016
$1.4M
NCI NIH HHS P30 CA125123NICHD NIH HHS R01 HD100985NIDDK NIH HHS K12 DK083014NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK078121NIDDK NIH HHS T32 DK007763
6 · The paper itself

Abstract

Despite the high prevalence of hypospadias and cryptorchidism, the genetic basis for these conditions is only beginning to be understood. Using array-comparative-genomic-hybridization (aCGH), potassium-channel-tetramerization-domain-containing-13 (KCTD13) encoded at 16p11.2 was identified as a candidate gene involved in hypospadias, cryptorchidism and other genitourinary (GU) tract anomalies. Copy number variants (CNVs) at 16p11.2 are among the most common syndromic genomic variants identified to date. Many patients with CNVs at this locus exhibit GU and/or neurodevelopmental phenotypes. KCTD13 encodes a substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3-ubiquitin-protein-ligase complex (BCR (BTB-CUL3-RBX1) E3-ubiquitin-protein-ligase complex (B-cell receptor (BCR) [BTB (the BTB domain is a conserved motif involved in protein-protein interactions) Cullin3 complex RING protein Rbx1] E3-ubiqutin-protein-ligase complex), which has essential roles in the regulation of cellular cytoskeleton, migration, proliferation, and neurodevelopment; yet its role in GU development is unknown. The prevalence of KCTD13 CNVs in patients with GU anomalies (2.58%) is significantly elevated when compared with patients without GU anomalies or in the general population (0.10%). KCTD13 is robustly expressed in the developing GU tract. Loss of KCTD13 in cell lines results in significantly decreased levels of nuclear androgen receptor (AR), suggesting that loss of KCTD13 affects AR sub-cellular localization. Kctd13 haploinsufficiency and homozygous deletion in mice cause a significant increase in the incidence of cryptorchidism and micropenis. KCTD13-deficient mice exhibit testicular and penile abnormalities together with significantly reduced levels of nuclear AR and SOX9. In conclusion, gene-dosage changes of murine Kctd13 diminish nuclear AR sub-cellular localization, as well as decrease SOX9 expression levels which likely contribute in part to the abnormal GU tract development in Kctd13 mouse models and in patients with CNVs in KCTD13.

Indexed as

CryptorchidismHypospadiasAndrogensAnimalsGene DosageHomozygoteHumansMaleMiceNuclear ProteinsPotassiumReceptors, AndrogenReceptors, Antigen, B-CellSequence DeletionUbiquitin-Protein Ligase ComplexesUbiquitin-Protein LigasesAndrogensKCTD13 protein, humanNuclear ProteinsPDIP1 protein, mousePotassiumReceptors, AndrogenReceptors, Antigen, B-CellUbiquitin-Protein Ligase ComplexesUbiquitin-Protein LigasesUbiquitinscopy number variantcryptorchidismKCTD13penile anomalies

Identifiers

PMID36196997
PMCPMC10538574
OpenAlexW4301603231

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.